DCAF7 and nasopharyngeal carcinoma: To explore the specific mechanisms of DCAF7 in NPC progression, we conducted coimmunoprecipitation (co‐IP) followed by MS (IP–MS) to identify the potential targets of DCAF7 (Figure 3A).